MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-43-0061566
Napcure Pharmaceuticals Private Limited
Napcure Pharmaceuticals Private Limited - healthcare in Lucknow, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹7.25 Lakh
▼ 65% YoY
Net profit · FY 2024
₹16,508
Net margin 2.3%
EBITDA · FY 2024
₹2.38 Lakh
EBITDA margin 32.9%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹20 Lakh
Secured borrowings
Company age
14 yrs
Est. 2012
Directors on board
2
As per MCA filings
About Napcure Pharmaceuticals Private Limited
Data last updated:
Napcure Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the other hospital and medical care activities segment of the healthcare sector. It was incorporated on 10 December 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U74120UP2012PTC054040.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Nilesh Mishra and Sangeeta Shukla.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at E – 4/313 Rajnikhand Near Raibareli Road Sharda Nagar, Lucknow, Uttar Pradesh, India – 226025.
As per the financials filed for FY 2024, the company reported a revenue of ₹7.25 Lakh, a decline of 65% compared to the previous year. For the same year it recorded a net profit of ₹16,508 (net margin 2.3%) and EBITDA of ₹2.38 Lakh (EBITDA margin 32.9%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years.
As per MCA filings, the company has open charges of ₹20 Lakh on record.
Napcure Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-43-0061566). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74120UP2012PTC054040
Registration Number 054040
Incorporation Date 10 December 2012
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UP-43-0061566
Key People
Nilesh Mishra Director Sangeeta Shukla Director Recognitions & Rankings of Napcure Pharmaceuticals
Contact details
Napcure Pharmaceuticals Private Limited's registered office is in Lucknow, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressE – 4/313 Rajnikhand Near Raibareli Road Sharda Nagar, Lucknow, Uttar Pradesh, India – 226025
- IndustryHealthcare, Other Hospital And Medical Care Activities
To see the full contact details of Napcure Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Napcure Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Napcure Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Napcure Pharmaceuticals Private Limited, buy the company report.
Financials of Napcure Pharmaceuticals Private Limited
FY 2024 filings availableNapcure Pharmaceuticals Private Limited reported revenue of ₹7.25 Lakh (down 65% YoY) for FY 2024.
Revenue · FY 2024
₹7.25 Lakh ▼ 65%
Net profit · FY 2024
₹16,508 margin 2.3%
EBITDA · FY 2024
₹2.38 Lakh margin 32.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 65%
3 years · compounded
▲ 4%
EBITDA CAGR growth
1 year
▲ 15%
3 years · compounded
▲ 49%
Revenue fell 65% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 4%. EBITDA rose 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.38 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹16,508 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 32.9% | ||||
| Net Profit Margin | 2.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Napcure Pharmaceuticals Private Limited, buy the company report.
Board of directors of Napcure Pharmaceuticals Private Limited
Napcure Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nilesh Mishra | Director | 10 Dec 2012 | 13 Years 10 Months | Current |
| Sangeeta Shukla | Director | 20 Aug 2018 | 8 Years 2 Months | Current |
Peer comparison
Napcure Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| SP Pharmaceuticals Private Limited | ₹7.29 Lakh (FY 2024) | 7.0% | Ulhasnagar, Maharashtra, India | |||
| Accedo Pharmaceuticals Private Limited | ₹7.27 Lakh (FY 2017) | 85.0% | Kolkata, West Bengal, India | |||
| PN Pharmaceuticals Private Limited | ₹7.27 Lakh (FY 2023) | 30.0% | Noida, Uttar Pradesh, India | |||
| Napcure Pharmaceuticals Private Limitedthis company | ₹7.25 Lakh (FY 2024) | ₹16,508 | 2.3% | -65.0% | Lucknow, Uttar Pradesh, India | |
| Sunbow Pharmaceuticals Private Limited | ₹7.21 Lakh (FY 2025) | -37.0% | Guwahati, Assam, India | |||
| Vixen Pharmaceuticals Private Limited | ₹7.13 Lakh (FY 2020) | 32.0% | Kaithal, Haryana, India |
To see the full peer comparison of Napcure Pharmaceuticals Private Limited, buy the company report.
Auditor
Napcure Pharmaceuticals Private Limited is audited by ARUNKUMARSHARMA for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ARUNKUMARSHARMA | FY 2017 | 412166 |
Shareholding
The shareholding of Napcure Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Napcure Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹20 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 02 Nov 2020 | 100395538 | Others | ₹20 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Napcure Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Napcure Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Napcure Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Napcure Pharmaceuticals Private Limited has 4 board changes on record since 2012: 2 appointments and 2 cessations. The latest: Anand Kumar Prajapati ceased to be Director on 21 Aug 2018.
AGM
Napcure Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Napcure Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Uttar Pradesh I.
Charges
A charge with Others amounted to Rs. 20.00 Lakh with Charge ID 100395538 was registered on 02 Nov 2020.
Ceased
Anand Kumar Prajapati ceased to be Director.
Ceased
Pawan Kumar Tiwari ceased to be Director.
Appointed
Sangeeta Shukla was appointed as Director.
Appointed
Nilesh Mishra was appointed as Director.
Incorporation
10 Dec 2012
Napcure Pharmaceuticals Private Limited was registered on 10 Dec 2012 with Roc Uttar Pradesh I & aged 13 years 10 months as per MCA records.
Frequently asked questions
Napcure Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in other hospital and medical care activities, within the healthcare industry. It was incorporated on 10 December 2012 (14+ years old) and is registered under CIN U74120UP2012PTC054040.
Napcure Pharmaceuticals has 2 current directors:
- Nilesh Mishra - Director
- Sangeeta Shukla - Director
The latest financial statements of Napcure Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Napcure Pharmaceuticals is U74120UP2012PTC054040. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Napcure Pharmaceuticals was incorporated on 10 December 2012, making it 14+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Napcure Pharmaceuticals by revenue are SP Pharmaceuticals Private Limited, Accedo Pharmaceuticals Private Limited, PN Pharmaceuticals Private Limited, Sunbow Pharmaceuticals Private Limited, Vixen Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Anand Kumar Prajapati ceased to be Director on 21 Aug 2018. Pawan Kumar Tiwari ceased to be Director on 21 Aug 2018. Sangeeta Shukla was appointed as Director on 20 Aug 2018. Napcure Pharmaceuticals has 4 board changes on record in total.
Yes, Napcure Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-43-0061566).
The registered office of Napcure Pharmaceuticals is at E – 4313 Rajnikhand Near Raibareli Road Sharda Nagar, Lucknow, Uttar Pradesh, India – 226025.
Napcure Pharmaceuticals operates in the healthcare industry, in the other hospital and medical care activities segment.
Napcure Pharmaceuticals has open charges of ₹20 Lakh and no satisfied charges on record as per latest MCA filings.